Connect with us

Hi, what are you looking for?

Stock

Biogen Earnings, Revenue Beat in Q1

Stock Markets4 minutes ago (Apr 22, 2021 07:07AM ET)

(C) Reuters. Biogen Earnings, Revenue Beat in Q1

Investing.com – Biogen (NASDAQ:BIIB) reported on Thursday first quarter earnings that beat analysts’ forecasts and revenue that topped expectations.

Biogen announced earnings per share of $5.34 on revenue of $2.69B. Analysts polled by Investing.com anticipated EPS of $5.02 on revenue of $2.66B.

Biogen shares are up 10% from the beginning of the year, still down 25.85% from its 52 week high of $363.92 set on November 4, 2020. They are outperforming the Nasdaq which is up 8.24% from the start of the year.

Biogen’s report follows an earnings beat by J&J on Tuesday, who reported EPS of $2.59 on revenue of $22.32B, compared to forecasts EPS of $2.33 on revenue of $22.01B.

Abbott Labs had beat expectations on Tuesday with first quarter EPS of $1.32 on revenue of $10.46B, compared to forecast for EPS of $1.27 on revenue of $10.69B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar

Biogen Earnings, Revenue Beat in Q1

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Uncategorized

Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt.

Uncategorized

Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione.

Uncategorized

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum.

Uncategorized

Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora.

Disclaimer: Buzzclever.com it's managers and its employees (collectively "The Company") do not make any guarantee or warranty about what is advertised or above. Information provided by this website is for research purposes only and should not be considered as personalized financial or health advice. Copyright © 2021 Buzz Clever. All Rights Reserved